Paper848799
Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
Franciosa JA and 2 others. Ann Intern Med, 1977. Cited by 232 papers, by iCite.
Cite this record
ConductScience Library. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Papers, record 848799. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/848799
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferricyanides | Major topic |
| Heart Failure | Major topic |
| Hemodynamics | Major topic |
| Hydralazine | Major topic |
| Nitroprusside | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Blood Pressure | |
| Cardiac Output | |
| Heart Ventricles | |
| Humans | |
| Infusions, Parenteral | |
| Male | |
| Middle Aged | |
| Vascular Resistance |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 232 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21874282 | Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators. | Curr Heart Fail Rep | 2012 | https://conductscience.org/library/papers/21874282 | PubMed |
| 18488879 | Carvedilol in the treatment of elderly patients with chronic heart failure. | Clin Interv Aging | 2008 | https://conductscience.org/library/papers/18488879 | PubMed |
| 15226814 | Afterload reduction in the therapy of heart failure. | Tex Heart Inst J | 1982 | https://conductscience.org/library/papers/15226814 | PubMed |
| 9885099 | Outpatient management of congestive heart failure. | Tex Heart Inst J | 1998 | https://conductscience.org/library/papers/9885099 | PubMed |
| 8086321 | Treatment of infarct related heart failure: vasodilators other than ACE inhibitors. | Cardiovasc Drugs Ther | 1994 | https://conductscience.org/library/papers/8086321 | PubMed |
| 7426183 | Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure. | Br Heart J | 1980 | https://conductscience.org/library/papers/7426183 | PubMed |
| 7318877 | Clinical pharmacology of tolmesoxide in refractory heart failure. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7318877 | PubMed |
| 7287364 | Pharmacokinetic and haemodynamic studies with prazosin in chronic heart failure. | Ir J Med Sci | 1981 | https://conductscience.org/library/papers/7287364 | PubMed |
| 7253539 | Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure. | Klin Wochenschr | 1981 | https://conductscience.org/library/papers/7253539 | PubMed |
| 7225252 | Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. | Br Heart J | 1981 | https://conductscience.org/library/papers/7225252 | PubMed |
| 6994981 | Clinical pharmacokinetics of prazosin. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/6994981 | PubMed |
| 6785251 | Afterload reduction in the therapy of heart failure. | Ir J Med Sci | 1980 | https://conductscience.org/library/papers/6785251 | PubMed |
| 6753903 | Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6753903 | PubMed |
| 6753895 | Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6753895 | PubMed |
| 6349967 | Vasodilator therapy in chronic congestive heart failure. | Drugs | 1983 | https://conductscience.org/library/papers/6349967 | PubMed |
| 6349763 | Vasodilators. | Can Med Assoc J | 1983 | https://conductscience.org/library/papers/6349763 | PubMed |
| 6125370 | Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification. | Drugs | 1982 | https://conductscience.org/library/papers/6125370 | PubMed |
| 6112039 | Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6112039 | PubMed |
| 3758138 | The search of an ideal oral positive inotropic agent. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3758138 | PubMed |
| 3304372 | Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects. | Br Heart J | 1987 | https://conductscience.org/library/papers/3304372 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/848799
GET https://conductscience.org/api/papers/v1/848799/cited_by?page=2